Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
| BLT | CORPORATE PRESENTATION | 24/04/18 | ||
| BLT | CLINICAL PROGRAM UPDATE | PRICE SENSITIVE | 24/04/18 | |
| BLT | Appendix 3B | 12/04/18 | ||
| BLT | Appendix 3B | 21/03/18 | ||
| BLT | Presentation at ROTH Conference | 14/03/18 | ||
| BLT | BENITEC TO PRESENT AT ROTH CONFERENCE | 13/03/18 | ||
| BLT | PHASE 2 ONCOLOGY STUDY LAUNCHED | PRICE SENSITIVE | 05/03/18 | |
| BLT | QUARTERLY CORPORATE CALL TRANSCRIPT | 23/02/18 | ||
| BLT CORPORATE PRESENTATION | |||
| 24/04/18 | |||
| BLT CLINICAL PROGRAM UPDATE | |||
| 24/04/18 | PRICE SENSITIVE | ||
| BLT Appendix 3B | |||
| 12/04/18 | |||
| BLT Appendix 3B | |||
| 21/03/18 | |||
| BLT Presentation at ROTH Conference | |||
| 14/03/18 | |||
| BLT BENITEC TO PRESENT AT ROTH CONFERENCE | |||
| 13/03/18 | |||
| BLT PHASE 2 ONCOLOGY STUDY LAUNCHED | |||
| 05/03/18 | PRICE SENSITIVE | ||
| BLT QUARTERLY CORPORATE CALL TRANSCRIPT | |||
| 23/02/18 | |||
